6xqu | pdb_00006xqu
From Proteopedia
Extreme malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals: Prospects for repurposing existing drugs and ramifications for inhibitor design
| ||||||||||||
Structural highlights
See AlsoContents | ||||||||||||||||||||
This page was last modified 10:43, 23 October 2024.